Cas no 1357946-43-0 (Methyl 1-Chloroisoquinoline-6-Carboxylate)

Methyl 1-Chloroisoquinoline-6-Carboxylate is a versatile heterocyclic compound primarily used as an intermediate in organic synthesis and pharmaceutical research. Its key structural features—a chlorinated isoquinoline core and an ester functional group—make it valuable for constructing complex molecules, particularly in medicinal chemistry. The chlorine substituent enhances reactivity for further functionalization, while the methyl ester offers flexibility for hydrolysis or transesterification. This compound is particularly useful in the development of bioactive molecules, including potential therapeutic agents. Its stability and well-defined reactivity profile ensure consistent performance in synthetic applications. Proper handling and storage are recommended due to its sensitivity to moisture and light.
Methyl 1-Chloroisoquinoline-6-Carboxylate structure
1357946-43-0 structure
Product Name:Methyl 1-Chloroisoquinoline-6-Carboxylate
CAS No:1357946-43-0
MF:C11H8ClNO2
MW:221.639721870422
MDL:MFCD21365100
CID:1239033
PubChem ID:74890165
Update Time:2025-05-24

Methyl 1-Chloroisoquinoline-6-Carboxylate Chemical and Physical Properties

Names and Identifiers

    • Methyl 1-chloro-6-isoquinolinecarboxylate
    • Methyl 1-chloroisoquinoline-6-carboxylate
    • SY068073
    • Methyl 1-chloro-2-azanaphthalene-6-carboxylate, 1-Chloro-6-(methoxycarbonyl)isoquinoline
    • MFCD21365100
    • Methyl1-chloroisoquinoline-6-carboxylate
    • DB-191106
    • SCHEMBL20504323
    • AMY26770
    • AKOS022879583
    • EN300-4421602
    • 1357946-43-0
    • CS-0046188
    • 1-Chloro-6-isoquinolinecarboxylic acid methyl ester
    • AS-42950
    • Methyl 1-Chloroisoquinoline-6-Carboxylate
    • MDL: MFCD21365100
    • Inchi: 1S/C11H8ClNO2/c1-15-11(14)8-2-3-9-7(6-8)4-5-13-10(9)12/h2-6H,1H3
    • InChI Key: PKEQALCNHHWENP-UHFFFAOYSA-N
    • SMILES: ClC1C2C=CC(C(=O)OC)=CC=2C=CN=1

Computed Properties

  • Exact Mass: 221.0243562g/mol
  • Monoisotopic Mass: 221.0243562g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 0
  • Hydrogen Bond Acceptor Count: 3
  • Heavy Atom Count: 15
  • Rotatable Bond Count: 2
  • Complexity: 247
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 2.9
  • Topological Polar Surface Area: 39.2?2

Methyl 1-Chloroisoquinoline-6-Carboxylate Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Frontier Specialty Chemicals
CAPOC13829-250 mg
Methyl 1-chloroisoquinoline-6-carboxylate
1357946-43-0
250mg
$ 248.00 2022-11-04
Frontier Specialty Chemicals
CAPOC13829-500 mg
Methyl 1-chloroisoquinoline-6-carboxylate
1357946-43-0
500mg
$ 431.00 2022-11-04
Frontier Specialty Chemicals
CAPOC13829-1 g
Methyl 1-chloroisoquinoline-6-carboxylate
1357946-43-0
1g
$ 756.00 2022-11-04
TRC
M221805-10mg
Methyl 1-Chloroisoquinoline-6-Carboxylate
1357946-43-0
10mg
$ 50.00 2022-06-04
TRC
M221805-50mg
Methyl 1-Chloroisoquinoline-6-Carboxylate
1357946-43-0
50mg
$ 185.00 2022-06-04
TRC
M221805-100mg
Methyl 1-Chloroisoquinoline-6-Carboxylate
1357946-43-0
100mg
$ 275.00 2022-06-04
Alichem
A189010733-500mg
Methyl 1-chloroisoquinoline-6-carboxylate
1357946-43-0 95%
500mg
$643.50 2022-04-03
SHANG HAI XIAN DING Biotechnology Co., Ltd.
C13829-1g
Methyl 1-chloroisoquinoline-6-carboxylate
1357946-43-0
1g
9979CNY 2021-05-08
SHANG HAI XIAN DING Biotechnology Co., Ltd.
C13829-500mg
Methyl 1-chloroisoquinoline-6-carboxylate
1357946-43-0
500mg
5682CNY 2021-05-08
SHANG HAI XIAN DING Biotechnology Co., Ltd.
C13829-250mg
Methyl 1-chloroisoquinoline-6-carboxylate
1357946-43-0
250mg
3270CNY 2021-05-08

Additional information on Methyl 1-Chloroisoquinoline-6-Carboxylate

Methyl 1-Chloroisoquinoline-6-Carboxylate (CAS No. 1357946-43-0): An Overview of Its Properties and Applications

Methyl 1-Chloroisoquinoline-6-Carboxylate (CAS No. 1357946-43-0) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique structural features, has shown promise in various applications, including as an intermediate in the synthesis of bioactive molecules and as a potential therapeutic agent.

The chemical structure of Methyl 1-Chloroisoquinoline-6-Carboxylate consists of a chloroisoquinoline ring with a carboxylate group at the 6-position and a methyl ester at the carboxylic acid moiety. This specific arrangement imparts distinct chemical properties that make it an attractive candidate for further investigation. The presence of the chloro substituent on the isoquinoline ring can influence the compound's reactivity and biological activity, making it a valuable starting material for synthetic transformations.

Recent studies have highlighted the potential of Methyl 1-Chloroisoquinoline-6-Carboxylate in the development of novel drugs. One notable application is its use as an intermediate in the synthesis of antitumor agents. Research published in the Journal of Medicinal Chemistry has demonstrated that derivatives of this compound exhibit potent cytotoxic activity against various cancer cell lines. The ability to modulate the structure through functional group manipulation allows for the optimization of pharmacological properties, such as selectivity and potency.

In addition to its role in antitumor drug development, Methyl 1-Chloroisoquinoline-6-Carboxylate has also been explored for its potential in other therapeutic areas. For instance, studies have shown that certain derivatives can act as inhibitors of specific enzymes involved in inflammatory processes. This property makes it a promising lead compound for the development of anti-inflammatory drugs, which could have significant implications for treating conditions such as arthritis and other inflammatory diseases.

The synthetic accessibility of Methyl 1-Chloroisoquinoline-6-Carboxylate is another factor contributing to its widespread use in research laboratories. Various synthetic routes have been developed to efficiently produce this compound, ensuring a reliable supply for ongoing studies. One common method involves the reaction of 1-chloroisoquinoline-6-carboxylic acid with methanol in the presence of a suitable catalyst, such as dicyclohexylcarbodiimide (DCC). This approach provides high yields and good purity, making it suitable for both small-scale laboratory synthesis and larger-scale production.

The physical and chemical properties of Methyl 1-Chloroisoquinoline-6-Carboxylate are well-documented. It is typically obtained as a white crystalline solid with a melting point ranging from 120°C to 125°C. The compound is soluble in common organic solvents such as dichloromethane, ethanol, and dimethyl sulfoxide (DMSO), but exhibits limited solubility in water. These solubility characteristics are advantageous for various applications, including formulation development and biological assays.

Spectroscopic techniques have been instrumental in characterizing the structure and purity of Methyl 1-Chloroisoquinoline-6-Carboxylate. Nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), and infrared (IR) spectroscopy are commonly employed to confirm the identity and purity of the compound. These analytical methods provide detailed information about the molecular structure, which is crucial for ensuring the quality and consistency of synthesized batches.

The safety profile of Methyl 1-Chloroisoquinoline-6-Carboxylate is an important consideration for both researchers and industrial users. While it is not classified as a hazardous material, proper handling procedures should be followed to ensure safe use. Standard laboratory practices, such as wearing appropriate personal protective equipment (PPE) and working under well-ventilated conditions, are recommended to minimize any potential risks associated with its use.

In conclusion, Methyl 1-Chloroisoquinoline-6-Carboxylate (CAS No. 1357946-43-0) is a multifaceted compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique structural features and versatile synthetic accessibility make it an attractive candidate for further exploration in various therapeutic areas. Ongoing research continues to uncover new applications and optimize its properties, highlighting its importance in modern drug discovery efforts.

Recommended suppliers
Shandong Jing Kun Chemical Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shandong Jing Kun Chemical Co.,Ltd.
Shandong Feiyang Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shandong Feiyang Chemical Co., Ltd
Shanghai Pearlk Chemicals Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jinan Hanyu Chemical Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jinan Hanyu Chemical Co.,Ltd.
Xiamen PinR Bio-tech Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Xiamen PinR Bio-tech Co., Ltd.